PulseAugur
EN
LIVE 15:46:28

Insilico and Human Longevity partner on AI disease prediction models

By PulseAugur Editorial · [2 sources] ·

Insilico Medicine and Human Longevity have formed a partnership to develop AI foundation models aimed at predicting diseases decades in advance. This collaboration combines Insilico's AI algorithms with Human Longevity's genomic data to advance personalized health research. The venture targets the burgeoning global longevity market, which is valued in the trillions of dollars. AI

IMPACT This collaboration could accelerate the development of AI-driven personalized medicine and drug discovery.

RANK_REASON This is a partnership between two companies to develop AI models for a specific application, not a frontier model release or significant industry-wide event.

Read on SCMP — Tech →

AI-generated summary · Google Gemini · from 2 sources. How we write summaries →

Insilico and Human Longevity partner on AI disease prediction models

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
This is a partnership between two companies to develop AI models for a specific application, not a frontier model release or significant industry-wide event.
Source corroboration
2 independent sources
Multiple independent publishers reporting the same story raises confidence that it's real and newsworthy.
Topics
product, infra
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
110 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [2]

  1. SCMP — Tech TIER_1 English(EN) · Julie Zhang ·

    Insilico teams up with US firm to build AI models predicting disease decades ahead

    Hong Kong-listed artificial intelligence drug-discovery company Insilico Medicine has struck a collaboration with US-headquartered Human Longevity to co-develop what they describe as “the industry’s first large-scale” AI foundation models capable of predicting diseases – such as …

  2. Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] ·

    Insilico Medicine, the Hong Kong-listed AI drug discovery company, has teamed up with US-based Human Longevity to build what they call the industry first large-

    Insilico Medicine, the Hong Kong-listed AI drug discovery company, has teamed up with US-based Human Longevity to build what they call the industry first large-scale AI foundation models capable of predicting diseases like cancer decades before clinical symptoms appear. The partn…

    LINKS scmp.com/…/insilico-teams-us-firm-build-a…

RELATED ENTITIES

RELATED TOPICS